About La Mesa Cardiac Center
Clinical Trials at La Mesa Cardiac Center
During the past decade, La Mesa Cardiac Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on
average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "La Mesa Cardiac Center" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Abbott Medical Devices" with 1 trials
sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Chugai Pharma USA" with 1 trials sponsored and "Eisai Inc."
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "La Mesa Cardiac Center"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at La Mesa Cardiac Center
According to Clinical.Site data, the most researched conditions in "La Mesa Cardiac Center" are
"Atrial Fibrillation" (3 trials), "Atherosclerosis" (2 trials), "Heart Failure" (2 trials), "Atrial Flutter" (1 trials) and "Cardiovascular Disease" (1 trials). Many other conditions were trialed in "La Mesa Cardiac Center" in a lesser frequency.
Clinical Trials Intervention Types at La Mesa Cardiac Center
Most popular intervention types in "La Mesa Cardiac Center" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Empagliflozin" (2 trials), "Azimilide Dihydrochloride" (1 trials), "BO-653" (1 trials) and "Lorcaserin hydrochloride" (1 trials). Other intervention names were less common.
Clinical Trials Genders at La Mesa Cardiac Center
The vast majority of trials in "La Mesa Cardiac Center" are
8 trials for "All" genders.
Clinical Trials Status at La Mesa Cardiac Center
Currently, there are NaN active trials in "La Mesa Cardiac Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in La Mesa Cardiac Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in La Mesa Cardiac Center, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".